- 
          Pharmaceuticals
                                    - Our Products
- Radiology
- 
          Collaboration
                                    - Patient group donations
- Payments to Patients, Public and Media
- Collaborative working
- Completed collaborative working
- Transfers of value to Healthcare Professionals and HealthcareOrganisations
- How Bayer works together with Healthcare Professionals
- What the EFPIA Disclosure code is about
- Data Disclosure
 
- Donations and Grants
 
- Consumer Health
- CropScience
    
            Patient Group Donations 2024
      
  
  Bayer is committed to developing new and innovative therapies for severe and chronic diseases. Patient advocacy groups and other voluntary health organisations help increase disease awareness and effective interventions.
The most recent patient and voluntary health organisations to which Bayer has provided financial support are listed below.
Patient Group Donations (January-December 2024)
Correct at 7 May 2025
      Download patient-org-declaration-2024.pdf
    (PDF 247.8 KB)
 
PP-OTH-GB-1251
Previous years
      
                                                      
      January - December 2023
    (PDF 127.28 KB)
      
      Special Links
      
                                                      
      Methodology Note 2024
    (PDF 334.88 KB)
      
      